William Lis - Mar 21, 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Executive Chairman of the Board, Director
Signature
/s/ Jeet Mahal, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/23/2022, 06:01 PM
Previous filing
Jan 21, 2022
Next filing
Jun 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Award $0 +90K $0.00 90K Mar 21, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +7.5K $0.00 7.5K Mar 21, 2022 Voting Common Stock 7.5K $3.54 Direct F2
transaction JSPR Stock Option (right to buy) Award $0 +90K $0.00 90K Mar 21, 2022 Voting Common Stock 90K $3.54 Direct F3
transaction JSPR Stock Option (right to buy) Award $0 +100K $0.00 100K Mar 21, 2022 Voting Common Stock 100K $3.54 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of June 24, 2022 and June 27, 2022, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
F2 1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
F3 1/4th of the shares subject to the option vested on March 21, 2022, and 1/4th of the shares subject to the option shall vest on each of March 24, 2022, September 24, 2022 and March 24, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
F4 1/12th of the shares subject to the option shall vest on April 15, 2022, and 1/12th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive

Remarks:

Executive Chairman of the Board